• Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • New technique extends cancer-fighting cells’ potency in melanoma patients
  • 2:09
  • Scientists from Dana-Farber have developed a technique to prolong the effectiveness of "trained" white blood cells to attack tumors - in some cases for over a year - without the need for other, highly toxic treatments, a new study published in Science Translational Medicine shows.

    "The study demonstrates it is possible to maintain high levels of anti-tumor T cells in patients over a long period of time while avoiding the complications of conventional approaches," says the study's lead author, Marcus Butler, MD, of Dana-Farber’s Early Drug Development Center.

Tags: Melanoma